Shockwave Medical, Inc. (SWAV)

ShockWave Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	163.5	147.28	216	-9.14	-65.7	-51.11
Depreciation & Amortization	11.76	10.36	4.86	3.58	1.86	2.28
Other Amortization	2.42	1.51	0.53	0.51	0.65	0.44
Asset Writedown & Restructuring Costs	0.27	0.27	0.08	0.01	0.19	0.07
Loss (Gain) From Sale of Investments	-21.14	-11.96	-0.07	1.09	0.3	-0.54
Loss (Gain) on Equity Investments	0.33	1.87	2.48	6.29	-	-
Stock-Based Compensation	80.2	73.23	44.89	27.26	10.35	3.65
Other Operating Activities	6.79	17.35	-93.1	1.96	1.48	0.61
Change in Accounts Receivable	-37.55	-41.54	-33.31	-25.75	-4.31	-4.53
Change in Inventory	-26.54	-31.01	-29.71	-12.07	-17.06	-6.82
Change in Accounts Payable	-4.21	0.11	1.95	1.87	-1.39	1.27
Change in Income Taxes	2.97	1.53	-	-	-	-
Change in Other Net Operating Assets	19.11	27.05	3.15	19.43	2.45	6.59
Operating Cash Flow	197.93	196.05	117.73	15.04	-71.18	-48.11
Operating Cash Flow Growth	32.17%	66.53%	683.00%	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Capital Expenditures	-31.8	-30.6	-25.13	-12.44	-11.52	-3.82
Cash Acquisitions	-94.41	-94.41	-	-	-	-
Investment in Securities	-590.16	-500.72	-37.02	38.86	-95.95	-55.73
Investing Cash Flow	-716.36	-625.73	-62.15	26.42	-107.47	-59.54

Financing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-Term Debt Issued	-	810.46	24.17	-	3.27	-
Long-Term Debt Repaid	-	-105	-18.2	-	-1.11	-1.67
Net Debt Issued (Repaid)	625.46	705.46	5.97	-	2.15	-1.67
Issuance of Common Stock	9.21	7.6	7.05	5.89	89.48	209.72
Repurchase of Common Stock	-0.05	-0.04	-0.02	-8.34	-1.42	-
Other Financing Activities	-112.62	-112.62	-	-	-0.18	-
Financing Cash Flow	522	600.4	13	-2.45	90.04	208.05

Net Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Foreign Exchange Rate Adjustments	-3.17	0.8	-1.15	-	-	-
Net Cash Flow	0.4	171.52	67.43	39	-88.62	100.4

Free Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Free Cash Flow	166.14	165.46	92.61	2.6	-82.7	-51.92
Free Cash Flow Growth	37.61%	78.67%	3465.88%	-	-	-
Free Cash Flow Margin	21.08%	22.66%	18.91%	1.09%	-122.00%	-120.96%
Free Cash Flow Per Share	4.33	4.33	2.44	0.07	-2.50	-2.17
Levered Free Cash Flow	118.03	112.47	49.42	-0.31	-58.21	-33.84
Unlevered Free Cash Flow	121.37	115.27	50.06	-0.14	-58.1	-33.68

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash Interest Paid	5.33	1.88	0.79	0.59	0.55	0.53
Cash Income Tax Paid	12.17	7.89	2.16	0.14	0.02	0.12

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error